On-Demand Webinars

  1. Regulatory Compliance And Advanced Solutions For Aseptic Environmental Monitoring 1/29/2026

    Modern aseptic monitoring requires a shift from periodic checks to risk-based strategies. Learn how to integrate particle and environmental data to meet Annex 1 standards and ensure patient safety.

  2. Building Digitally Connected Packaging Operations With Open Standards 1/29/2026

    Connect shopfloor equipment with enterprise systems to streamline your data flow. Learn how automation standards enhance integration and see a live demonstration of unified line performance in action.

  3. Simplified Harvest And Media Exchange In Cell Therapy 1/28/2026

    Scale-up often introduces shear stress and process variability. Learn how low-shear, single-use technology stabilizes media exchange and harvest, ensuring consistent cell quality and predictable performance.

  4. Drug Product Development: Preclinical To Commercial 1/26/2026

    Watch a unified roadmap for drug product development, outlining phase‑appropriate studies, QTTP importance, and key requirements from preclinical stages through commercialization.

  5. Understanding Surfactant Excipients In Biologic Formulations 1/26/2026

    Uncover surfactant characterization, polysorbate degradation, and advanced analytics, such as multidimensional LC, to strengthen stability assessment and formulation for biologics and advanced therapies.

  6. Subvisible Particle Analysis For End‑To‑End Quality 1/26/2026

    See strategies for precise subvisible particle analysis, covering regulatory expectations, method validation, and controlling variability when transitioning workflows from R&D to GMP environments.

  7. Building A Path To A Successful AAV Product 1/26/2026

    See state‑of‑the‑art analytical methods for AAV characterization, key quality attributes to monitor, and approaches for measuring infectivity and full‑to‑empty capsid ratios.

  8. Lyo‑Modelling For Risk Reduction And Process Insights 1/26/2026

    Use lyophilization modelling to optimize freeze‑drying, boost product quality, and lower commercialization risks through predictive insights, robustness analysis, and deeper process understanding.

  9. Detecting Particles In Biologic And CGT Drug Products 1/26/2026

    Identify and characterize visible and subvisible particles that can form during biologic and cell or gene therapy development.

  10. Developability Assessment And Early Formulation Studies 1/26/2026

    Early developability and pre‑formulation screening build strong biophysical data, reduce late‑stage risks, support candidate selection, and streamline biologics development toward clinical success.